Spots Global Cancer Trial Database for gemtuzumab ozogamicin (mylotarg)
Every month we try and update this database with for gemtuzumab ozogamicin (mylotarg) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Mutation | NCT00893399 | Acute Myeloid L... | Gemtuzumab Ozog... standard chemot... | 18 Years - | University of Ulm |